Search Articles

View query in Help articles search

Search Results (1 to 10 of 2473 Results)

Download search results: CSV END BibTex RIS


Examining a Telemedicine-Based Virtual Reality Clinic in Treating Adults With Specific Phobia: Protocol for a Feasibility Randomized Controlled Efficacy Trial

Examining a Telemedicine-Based Virtual Reality Clinic in Treating Adults With Specific Phobia: Protocol for a Feasibility Randomized Controlled Efficacy Trial

After obtaining informed consent, supported by the REDCap e-Consent Framework feature, participants will be automatically directed to baseline questionnaire surveys, for which REDCap auto-calculates the scores. Following completion of the baseline assessment, the participant will be randomized to their respective treatment conduction using the Randomization Module.

Kaitlyn R Schuler, Triton Ong, Brandon M Welch, Jason G Craggs, Brian E Bunnell

JMIR Res Protoc 2025;14:e65770

Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application

Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application

Crenezumab and solanezumab were the most tolerable and safest antibodies in terms of ARIA-E and ARIA-H. All other antibodies substantially increased the risk of total ARIA-E (Table 3; Figure S5 in Multimedia Appendix 8). Heterogeneity was not significant for the risks of ARIA-E (I2=33.7%) and treatment dropouts due to AEs (I2=0%).

Danko Jeremic, Juan D Navarro-Lopez, Lydia Jimenez-Diaz

J Med Internet Res 2025;27:e68454